Pleuroparenchymal fibroelastosis: Its clinical characteristics

Current Respiratory Medicine Reviews

Volumn 9, Issue 4, 2013, Pages 229-237

  Watanabe, Kentaro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Pleuroparenchymal fibroelastosis (PPFE); Pulmonary fibrosis (IPF); Pulmonary upper lobe fibrosis

Indexed keywords

ALUMINUM 26; ASBESTOS; GLYCOPROTEIN; GLYCOPROTEIN KL 6; IMMUNOSUPPRESSIVE AGENT; STEROID; UNCLASSIFIED DRUG;

ALLERGIC PNEUMONITIS; ARTICLE; AUTOPSY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIGITAL CLUBBING; DUST EXPOSURE; DYSPNEA; ELASTOSIS; HUMAN; LUNG BIOPSY; LUNG FIBROSIS; LUNG INFECTION; MEDICAL HISTORY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; OCCUPATIONAL EXPOSURE; PHYSICAL EXAMINATION; PLEUROPARENCHYMAL FIBROELASTOSIS; PNEUMOTHORAX; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SMOKING; STEROID THERAPY;

EID: 84893514074     PISSN: 1573398X     EISSN: 18756387     Source Type: Journal    
DOI: 10.2174/1573398X0904140129125307     Document Type: Article

References (51)

1. Frankel SK, Cool CD, Lynch DA, Brown KK. Idiopathic pleuroparenchymal fibroelastosis. Description of a novel clinicopathologic Entity. Chest 2004; 126: 2007-13.
2. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Amer J Respir Crit Care Med 2013; 188: 733-48.
3. Davies D, Crowther JS, MacFarlane A. Idiopathic progressive pulmonary fibrosis. Thorax 1975; 30(3): 316-25.
4. Davies D. Ankylosing spondylitis and lung fibrosis. Q J Med 1972; 41: 395-417.
5. Clinicopathological Conference. Undiagnosable lung disease demonstrated at the postgraduate medical school of London. Br Med J 1962; 1: 1403-10.
6. Clinicopathological Conference. A Case of idiopathic cavitation of lung demonstrated at the postgraduate medical school of London. Br Med J 1966; 1(5483): 345-8.
7. Kentala E, Repo UK, Lehtipuu AL, Vuornos T. HLA-antigens and pulmonary upper lobe fibrocystic changes with and without ankylosing spondylitis. A report of seven cases. Scand J Respir Dis 1978; 59: 8-12.
8. Repo UK, Kentala E, Koistinen J, et al. Pulmonary apical fibrocystic disease. A serologic study. Eur J Respir Dis 1981; 62: 46-55.
9. Fraisse P, Vandevenne A, Ducolone A, Burghard G. Idiopathic progressive pleuropulmonary fibrosis. Apropos of 2 cases. Rev Pneumol Clin 1984; 40(2): 139-43.
10. Amitani R, Niimi A, Kuze F. Idiopathic pulmonary upper lobe fibrosis. Kokyu 1992; 11: 693-9.
11. Kobayashi Y, Sakurai M, Kushiya M, et al. Idiopathic pulmonary fibrosis of the upper lobe: a case report. Nihon Kokyuki Gakkai Zasshi 1999; 37: 812-6.
12. Jingu K, Kawana A, Furihata K, et al. Two cases of marked pulmonary fibrosis in the upper lung field. Kokyu 1999; 18: 318-23.
13. Shiota S, Shimizu K, Suzuki M, et al. Seven cases of marked pulmonary fibrosis in the upper lobe. Nihon Kokyuki Gakkai Zasshi 1999; 37: 87-96.
14. Kobashi Y, Ohba H, Yoneyama H, et al. A case of so-called "idiopathic pulmonary upper lobe fibrosis" complicated by both mediastinal emphysema and bilateral pneumothorax at different rimes. Kokyu 2000; 19: 292-8.
15. Iwama N, Maehira N, Takahashi S, Chiba R. A case of idiopathic pulmonary upper lobe fibrosis. Shindan Byori 2000; 17: 249-51.
16. Fuke S, Betsuyaku T, Oizumi S, Nasuhara Y, Saito H, Yamaguchi E, Nishimura M. A case of idiopathic pulmonary upper lobe fibrosis complicated by invasive pulmonary aspergillosis. Nihon Kokyuki Gaskkai Zasshi 2003; 41: 196-201.
17. Kawabata Y, Matsuoka R. Pathology of idiopathic pulmonary upper lobe fibrosis. Nihon Kyobu Rinsho 62: S161-S202.
18. Iesato K., Ogasawara T, Masuda A, et al. Idiopathic pulmonary upper lobe fibrosis; clinical and pathological features. Rinsho Houshasen 2005; 50:13-25.
19. Nei T, Kawamoto M, Satoh E, et al. A case of suspected idiopathic pulmonary upper lobe fibrosis (Amitani disease) with acute exacerbation. Nihon Kokyuki Gakkai Zasshi 2009; 47: 116-21.
20. Kaneko Y, Kikuchi N, Ishii Y, et al. Upper lobe-dominant pulmonary fibrosis showing deposits of hard metal component in the fibrotic lesions. Intern Med 2010; 49: 2143-5.
21. Morimoto A, Mochizuki Y, Nakahara Y, Kawamura T, Sakaki S, Kobashi Y. A case of idiopathic pulmonary upper lobe fibrosis. Nihon Kokyuki Gakkai Zasshi 2010; 48: 944-49.
22. Satoh S, Kawai S, Usui T, Isogai S, Taura S, Nakaminato S. A case of idiopathic pulmonary upper lobe fibrosis. Rinsho Hoshasen 2010; 55: 211-4.
23. Watanabe K, Nagata N, Kitasato Y, et al. Rapid decrease in vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir Investig 2012; 50: 88-97.
24. Nakasone E, Bando M, Nakao T, Yamasawa H, Sugiyama YM. Pleuroparenchymal fibroelastosis in patients with pulmonary disease after bone marrow transplantation. Nihon Kokyuki Gakkai Zasshi 2012; 1: 562-6.
25. Nagashima O, Matsuno K, Tominaga S, Takahashi K. Esophageal diverticulum with idiopathic pulmonary upper lobe fibrosis. Intern Med 2013; 52(1): 159.
26. Inuzuka K, Yasui M, Waseda Y, Takato H, Ichikawa Y, Fujimura M. A case of repeated bilateral pneumothorax associated with upper lobe predominat fibrosis in an aluminum processing worker. Nihon Kokyukigakkai Zasshi 2010; 48; 492-6.
27. Becker CD, Gil J, Padilla ML. Idiopthic pleuroparenchymal fibroelstosis: an unrecognized or misdiagnosed entitiy? Modern Pathol 2008; 21: 784-7.
28. Von der Thusen JH, Hansell DM, Tominaga M, et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Modern Pathol 2011; 24: 1633-9.
29. Piciucchi S, Tomassetti S, Gasoni G, et al. High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: Features and differential diagnosis. Respir Res 2011; 12: 111.
30. Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis; a spectrum of histopathological and imaging phenotypes. Eur Respir J 2012; 40: 377-85.
31. Kusagaya H, Nakamura Y, Kono M, et al. Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients. BMC Pulmonary Medicine 2012; 12: 72.
32. Ofek E, Sato M, Saito T, et al. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis. Modern Pathol 2013; 26: 350-6.
33. Hirota T, Fujita M, Matsumoto T, et al. Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection? Eur Respir J 2013; 41: 243-5.
34. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Amer J Respir Crit Care Med 2002; 165: 277-304.
35. Tanaka H, Watanabe K, Tamaru N, et al. A case of alminium-induced pulmonary fibrosis. Kokyu 1989; 8: 435-9.
36. Singh R, Sundaram P, Joshi JM. Upper lobe fibrosis in ulcerative colitis. J assoc Physicians India 2003; 51: 515-7.
37. Bourke S, Campbell J, Henderson AF, Stevenson RD. Apical pulmonary fibrosis in psoriasis. Br J Dis Chest 1988; 82: 444-6.
38. Ryu JH, Colby TV, Hartman TE, Vassallo R. Smoking-related interstitial lung diseases; a concise review. Eur Respir J 2001; 17: 122-32.
39. Hamada K, Nagai S, Kitaichi M, et al. Cyclophosphamide-induced lateonset lung disease. Intern Med 2003; 42: 82-7.
40. Konen Eli, Weisbrod GL, Pakhale S, Chung TB, Paul MS, Hutcheon MA. Fibrosis of the upper lobes: A newly identified late-onset complication after lung transplantation? Amer J Roentgenol 2003; 181: 1539-43.
41. Pakhale SS, Hadjiliadis D, Howell DN, et al. Upper lobe fibrosis: A novel manifestation of chronic allograft dysfunction in lung transplantation. J Heart Lung Transpl 2005; 24: 1260-8.
42. Wick MR, Kendall TJ, Ritter JH. Asbestosis: demonstration of distinctive interstitial fibroelastosis. A pilot study. Ann Diag Pathol 2009; 13: 297-302.
43. Calabrese F, Alessandrini L, Loy M, et al. Comparison between referral diagnosis of patients requiring transplantation and pathologic diagnosis of native lungs. J Heart Lung Transpl 2009; 28: 1135-40.
44. Petrie GR, Bloomfield P, Grant IW, Crompton GK. Upper lobe fibrosis and cavitation in rheumatoid disease. Br J Dis Chest 1980; 74: 263-7.
45. Parish JM, Muhm JR, Leslie KO. Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation. Mayo Clin Proc 2003; 48: 630-4.
46. Harada T, Yoshida Y, Kitasato Y, et al. Thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelstosis. Eur Respir Rev 2013; in press.
47. Nath AR, Capel LH. Inspiratory crackles and mechanical events of breathing. Thorax 1974; 29: 695-8.
48. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989; 96: 68-73.
49. Ishikawa N, Hattori N, Yokoyama A, Kohno N. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases. Respir Investig 2012; 50: 3-13.
50. Zappala CJ, Latsi PI, Nicholson AG, et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J 2010; 35: 830-6.
51. Negir EM, Montes GS, Saldiva PHN, Capelozzi VL. Architectural remodeling in acute and chronic interstitial lung disease; fibrosis or fibroelastosis? Histopathology 2000; 37(5): 393-401.